Zeo ScientifiX, Inc. (ZEOX) income statement
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Apr 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX, Inc. income statement
Ratios
Latest available, balances at Apr 30, 2026
Profitability, TTM
- Gross margin
- 81.5%
- Operating margin
- -59.1%
- Net margin
- -55.6%
- Return on equity, FY2025
- 359.0%
Financial strength
- Current ratio
- 1.05
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 59.3%
Valuation
- P/E ratio
- –
- Price to sales
- 1.01
- Price to book
- 9.94
- Dividend yield
- –
See a number that looks wrong?